Clinical High Risk for Psychosis
15
2
2
7
Key Insights
Highlights
Success Rate
78% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
13.3%
2 terminated out of 15 trials
77.8%
-8.7% vs benchmark
7%
1 trials in Phase 3/4
43%
3 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (15)
Stratification and Treatment in Early Psychosis Study - PROMOTE
Individualized Vocational and Educational Support and Training for Clinical High Risk for Psychosis (InVEST)
Sacramento Clinical High Risk for Psychosis Stepped-Care Program
Feasibility of an Early Detection Program for Early Psychosis on a College Campus
Metacognitive Training in Ultra-high Risk
Endocannabinoid Activity Remodulation for Psychosis Liability in Youth
The Predictive Role of Self-representation in Transition of Individuals at Clinical High Risk for Psychosis
Targeted Cognitive Training in Clinical High Risk (CHR) for Psychosis
Gabapentin in Patients at Clinical Risk for Psychosis
Glutamate Reducing Interventions in Schizophrenia
Randomized Controlled Trial of Aspirin vs Placebo in the Treatment of Pre-psychosis
tDCS Coupled With Virtual Rehabilitation for Negative Symptoms in At-Risk Youth
Evaluation of the Treatment Approach ROBIN
Using Mobile Technology to Enhance Early Psychosis Treatment Delivery
Smartphone Applications Youth With Early Psychosis in Community Outpatient Settings